Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | SQLE | Q14534 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238726 | 1.00 | ALOX15 (0.46) | ALOX15KMT2AMEN1CYP3A4MAPT | |
| SCHEMBL10337451 | 1.00 | ALOX15 (0.46) | ALOX15KMT2AMEN1CYP3A4MAPT | |
| Farnesol SCHEMBL14973010 | 0.92 | KMT2A (0.59) | ALOX15KMT2AMEN1CYP3A4MAPT | |
| SCHEMBL10839164 | 0.79 | ALOX15 (0.57) | ALOX15KMT2AMEN1CYP3A4MAPT | |
| SCHEMBL10839159 | 0.79 | ALOX15 (0.57) | ALOX15KMT2AMEN1CYP3A4MAPT | |
| SCHEMBL11315940 | 0.79 | PTPN1 (0.53) | KMT2AMEN1TSHRPTPN1 | |
| SCHEMBL11315943 | 0.79 | PTPN1 (0.53) | KMT2AMEN1TSHRPTPN1 | |
| SCHEMBL11315939 | 0.79 | PTPN1 (0.53) | KMT2AMEN1TSHRPTPN1 | |
| SCHEMBL28817056 | 0.79 | ALOX15 (0.42) | ALOX15ALDH1A1TSHRSRCFNTA | |
| SCHEMBL6315751 | 0.79 | NR1I2 (0.46) | ALOX15KMT2AMEN1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | claimed |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-07-13 | — | — | US | claimed |
| EP-4153127-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-03-29 | — | — | EP | claimed |
| WO-2021234014-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2021-11-25 | — | — | WO | claimed |
| US-10555878-B2 | Solid antiperspirant and/or deodorant composition in the form of a water-in-oil emulsion based on silicone emulsifiers and on waxes; method for treating body odours | L'OREAL (FR) | 2020-02-11 | — | — | US | claimed |
| US-20140193471-A1 | SOLID ANTIPERSPIRANT AND/OR DEODORANT COMPOSITION IN THE FORM OF A WATER-IN-OIL EMULSION BASED ON SILICONE EMULSIFIERS AND ON WAXES; METHOD FOR TREATING BODY ODOURS | L'OREAL (FR) | 2014-07-10 | — | — | US | claimed |
| EP-1586304-B2 | Water in oil emulsion type deodorant cosmetic composition containing a polyolelfin derivative comprising at least one polar part as emulsifier | OREAL (FR) | 2011-08-17 | — | — | EP | claimed |
| US-20080119527-A1 | Composition for combating the localized hyperpigmentation of dark skin | L'OREAL (FR) | 2008-05-22 | — | — | US | claimed |
| EP-1900353-A1 | Composition to combat localised hyperpigmentation in dark skin types | L'OREAL (FR) | 2008-03-19 | — | — | EP | claimed |
| EP-1486199-B1 | Alcoholic aerosol deodorant composition containing zinc salicylate | OREAL (FR) | 2007-10-17 | — | — | EP | claimed |
| EP-1586304-A1 | Water in oil emulsion type deodorant cosmetic composition containing a polyolelfin derivative comprising at least one polar part as emulsifier | L'OREAL (FR) | 2005-10-19 | — | — | EP | claimed |
| EP-1584330-A1 | Oil in water emulsion-type antiperspirant composition containing wax microparticles | L'OREAL (FR) | 2005-10-12 | — | — | EP | claimed |
| EP-1550435-A1 | Deodorizing oil-in-water emulsion comprising a mixture of alkylpolyglycoside and fatty alcohol and a non ionic associative polyether polyurethane | L'OREAL S.A. (FR) | 2005-07-06 | — | — | EP | claimed |
| US-20050019288-A1 | Alcohol-based aerosol deodorant composition comprising at lease one zinc salicylate or a derivative thereof | L'OREAL S.A. (FR) | 2005-01-27 | — | — | US | claimed |
| EP-1486199-A1 | Alcoholic aerosol deodorant composition containing zinc salicylate or a derivative thereof | L'OREAL (FR) | 2004-12-15 | — | — | EP | claimed |
| WO-2003002078-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002080-A1 | COMPOSITIONS CONTAINING A DERIVATIVE OF HYDROXYDIPHENYL ETHER INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002081-A1 | COMPOSITION COMPRISING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002079-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002072-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'ORÉAL (FR) | 2003-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140193471-A1 | SOLID ANTIPERSPIRANT AND/OR DEODORANT COMPOSITION IN THE FORM OF A WATER-IN-OIL EMULSION BASED ON SILICONE EMULSIFIERS AND ON WAXES; METHOD FOR TREATING BODY ODOURS | DGAT1, DGAT2, DDT | ALOX15 263/4885KMT2A 2858/4885MEN1 4326/4885 |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | CUTA, EBP, ACMSD | ALOX15 677/4885KMT2A 2443/4885MEN1 4638/4885 |
| US-20050019288-A1 | Alcohol-based aerosol deodorant composition comprising at lease one zinc salicylate or a derivative thereof | ADH5, ADH1A, ADH1C | ALOX15 49/4885KMT2A 3693/4885MEN1 4140/4885 |
| US-10555878-B2 | Solid antiperspirant and/or deodorant composition in the form of a water-in-oil emulsion based on silicone emulsifiers and on waxes; method for treating body odours | DGAT1, DGAT2, DDT | ALOX15 263/4885KMT2A 2858/4885MEN1 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.